618 related articles for article (PubMed ID: 24284851)
1. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
3. Diabetic neuropathy: new strategies for treatment.
Várkonyi T; Kempler P
Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
Quilici S; Chancellor J; Löthgren M; Simon D; Said G; Le TK; Garcia-Cebrian A; Monz B
BMC Neurol; 2009 Feb; 9():6. PubMed ID: 19208243
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
7. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
Bellows BK; Dahal A; Jiao T; Biskupiak J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):153-64. PubMed ID: 22509775
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
Lindner MD; Bourin C; Chen P; McElroy JF; Leet JE; Hogan JB; Stock DA; Machet F
Exp Clin Psychopharmacol; 2006 Feb; 14(1):42-51. PubMed ID: 16503704
[TBL] [Abstract][Full Text] [Related]
9. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
10. Career lifetime advances and key developments: diabetes.
Baglioni P; Govindan J; Khan A
Clin Med (Lond); 2007 Jun; 7(3):303-4. PubMed ID: 17639617
[No Abstract] [Full Text] [Related]
11. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
[TBL] [Abstract][Full Text] [Related]
12. Clinical inquiry: what medications are best for diabetic neuropathic pain?
Page N; Deluca J; Crowell K
J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
Carlos F; Ramírez-Gámez J; Dueñas H; Galindo-Suárez RM; Ramos E
J Med Econ; 2012; 15(2):233-44. PubMed ID: 22082033
[TBL] [Abstract][Full Text] [Related]
15. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
Ziegler D; Schneider E; Boess FG; Berggren L; Birklein F
J Diabetes Complications; 2014; 28(5):698-704. PubMed ID: 24862108
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsants for fibromyalgia.
Üçeyler N; Sommer C; Walitt B; Häuser W
Cochrane Database Syst Rev; 2013 Oct; (10):CD010782. PubMed ID: 24129853
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews.
Wiffen PJ; Derry S; Moore RA; Aldington D; Cole P; Rice AS; Lunn MP; Hamunen K; Haanpaa M; Kalso EA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD010567. PubMed ID: 24217986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]